Cellid Co., Ltd. announced a private placement of 31,250 shares at KRW 48,000 per share for gross proceeds of KRW 1,500,000,000 with new investor, Amicogen Inc. on June 10, 2014. The investor will acquire 33.02% stake of the company through this transaction. The transaction has been approved by board of directors of the investor.

The scheduled acquisition date for the transaction is June 11, 2014. The company reported total assets of KRW 112,000,000, total stockholders' equity of KRW 112,000,000, capital of KRW 317,000,000, and net loss of KRW 13,000,000 for the year ended December 31, 2013.